GJA1 and breast cancer: Low expression of both membranous and cytoplasmic Cx43 showed a statistically significant association with breast cancer-specific survival (p < 0.0001; Fig. 2a, b; Table 2) with survival at 206 months compared to 244 months for low membrane expression and 200 months compared to 243 months for low cytoplasmic expression.